Related Experiment Video
Updated: Aug 1, 2026

11:36
Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs
Published on: April 21, 2012
Extensive levamisole-induced vasculitis
C Desvignes1, C Becquart1,2, D Launay2,3
1Department of Dermatology, Lille University Medical Centre, Claude Huriez Hospital, Lille, France.
Clinical and Experimental Dermatology
|April 12, 2017
Summary
Levamisole, a cocaine contaminant, can cause vasculitis. Dermatologists should suspect levamisole-induced skin conditions like purpura in drug users, as seen in a severe case report.
Area of Science:
- Immunodermatology
- Toxicology
- Rheumatology
Background:
- Levamisole is a common adulterant in illicit cocaine.
- Levamisole exposure is linked to antineutrophil cytoplasmic antibody-associated vasculitis.
- Cutaneous manifestations can be severe and indicative of systemic disease.
Purpose of the Study:
- To highlight the association between levamisole contamination in cocaine and vasculitis.
- To emphasize the importance of considering levamisole-induced cutaneous vasculopathy in drug users presenting with purpura.
- To report a severe case of levamisole-induced necrotic purpura.
Main Methods:
- Literature review on levamisole and vasculitis.
- Clinical case presentation of a 40-year-old female patient.
- Review of immunological abnormalities associated with levamisole exposure.
Main Results:
- Levamisole can induce antineutrophil cytoplasmic antibody-associated vasculitis.
- The patient presented with severe necrotic purpura and immunological abnormalities.
- Cocaine/levamisole-associated cutaneous vasculopathy syndrome is a potential diagnosis in affected individuals.
Conclusions:
- Dermatologists must consider levamisole-induced vasculopathy in drug users with purpura, especially of the ears or retiform pattern.
- Early diagnosis and recognition of levamisole as a contaminant are crucial for patient management.
- Levamisole poses a significant risk for severe dermatological and systemic complications.

